Eli Lilly and Company (LLY) Insider Trading & Ownership $732.41 +0.45 (+0.06%) Closing price 03:59 PM EasternExtended Trading$731.46 -0.95 (-0.13%) As of 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Eli Lilly and Company (NYSE:LLY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.13%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$2.89MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$1.54M Get LLY Insider Trade Alerts Want to know when executives and insiders are buying or selling Eli Lilly and Company stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LLY Insider Buying and Selling by Quarter Eli Lilly and Company Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/12/2025Daniel SkovronskyEVPBuy1,000$634.40$634,400.00 8/12/2025David A RicksCEOBuy1,632$644.77$1,052,264.64 8/12/2025Gabrielle SulzbergerDirectorBuy117$641.18$75,018.06 8/12/2025J Erik FyrwaldDirectorBuy1,565$642.33$1,005,246.45 8/8/2025Jamere JacksonDirectorBuy200$639.56$127,912.00 7/16/2025Lisa C. McClainU.S. Congress Member (R-MI)Sell$788.91$1,001 - $15,0007/10/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$790.23$1,001 - $15,0007/2/2025Ro KhannaU.S. Congress Member (D-CA)Buy$778.96$1,001 - $15,0006/9/2025Lisa C. McClainU.S. Congress Member (R-MI)Sell$773.59$1,001 - $15,0006/6/2025Ro KhannaU.S. Congress Member (D-CA)Buy$770.00$1,001 - $15,0006/3/2025Jonathan L. JacksonU.S. Congress Member (D-IL)Sell$750.94$15,001 - $50,0005/30/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Sell$738.33$1,001 - $15,0005/28/2025Ro KhannaU.S. Congress Member (D-CA)Sell$718.59$1,001 - $15,0005/14/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$716.19$1,001 - $15,0005/13/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$745.86$1,001 - $15,0005/12/2025Jefferson ShreveU.S. Congress Member (R-IN)Sell$755.28$100,001 - $250,0005/5/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$821.66$1,001 - $15,0005/1/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$794.67$1,001 - $15,0004/21/2025Jonathan L. JacksonU.S. Congress Member (D-IL)Buy$818.18$15,001 - $50,0004/21/2025Bruce WestermanU.S. Congress Member (R-AR)Sell$818.18$1,001 - $15,0004/15/2025Tommy TubervilleU.S. Congress Member (R-AL)Sell$756.55$15,001 - $50,0004/11/2025Dan NewhouseU.S. Congress Member (R-WA)Sell$731.62$1,001 - $15,0004/9/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$751.61$1,001 - $15,0004/8/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$723.92$1,001 - $15,0004/7/2025Julie JohnsonU.S. Congress Member (D-TX)Sell$722.03$1,001 - $15,0003/13/2025Donald A ZakrowskiCAOSell1,000$818.24$818,240.00 3/10/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$828.80$1,001 - $15,0003/3/2025Bruce WestermanU.S. Congress Member (R-AR)Buy$930.22$1,001 - $15,0002/19/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$866.69$1,001 - $15,0002/10/2025Ron WydenU.S. Congress Member (D-OR)Sell$868.57$50,001 - $100,0001/22/2025Ron WydenU.S. Congress Member (D-OR)Buy$753.65$50,001 - $100,0001/21/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$741.98$1,001 - $15,0001/8/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$786.15$1,001 - $15,00012/24/2024Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$795.67$1,001 - $15,00012/18/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$764.71$1,001 - $15,00012/16/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$779.02$1,001 - $15,00012/13/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$789.27$1,001 - $15,00012/12/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$782.35$1,001 - $15,00012/11/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$796.88$1,001 - $15,00012/10/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$800.85$1,001 - $15,00012/9/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$802.94$1,001 - $15,00011/19/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$729.62$1,001 - $15,00011/14/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$785.95$1,001 - $15,00011/8/2024Donald A ZakrowskiCAOSell900$803.38$723,042.00 (Data available from 1/1/2013 forward) LLY Insider Trading Activity - Frequently Asked Questions Who is on Eli Lilly and Company's Insider Roster? The list of insiders at Eli Lilly and Company includes Acquisition Corp Kearny, Alonzo Weems, Anne E White, Daniel Skovronsky, David A Ricks, Donald A Zakrowski, Gabrielle Sulzberger, J Erik Fyrwald, Jamere Jackson, Johna Norton, Lilly Endowment Inc, and Patrik Jonsson. Learn more on insiders at LLY. What percentage of Eli Lilly and Company stock is owned by insiders? 0.13% of Eli Lilly and Company stock is owned by insiders. Learn more on LLY's insider holdings. Which Eli Lilly and Company insiders have been buying company stock? The following insiders have purchased LLY shares in the last 24 months: Daniel Skovronsky ($634,400.00), David A Ricks ($1,052,264.64), Gabrielle Sulzberger ($75,018.06), J Erik Fyrwald ($1,005,246.45), and Jamere Jackson ($127,912.00). How much insider buying is happening at Eli Lilly and Company? Insiders have purchased a total of 4,514 LLY shares in the last 24 months for a total of $2,894,841.15 bought. Which Eli Lilly and Company insiders have been selling company stock? The following insiders have sold LLY shares in the last 24 months: Alonzo Weems ($678,445.04), Donald A Zakrowski ($2,538,521.50), Johna Norton ($5,781,545.28), and Lilly Endowment Inc ($1,439,297,958.43). How much insider selling is happening at Eli Lilly and Company? Insiders have sold a total of 1,844,658 Eli Lilly and Company shares in the last 24 months for a total of $1,448,296,470.25 sold. Which members of congress are trading Eli Lilly and Company? Lisa C. McClain (R-MI), Ro Khanna (D-CA), Marjorie Taylor Greene (R-GA), Josh Gottheimer (D-NJ), Jonathan L. Jackson (D-IL), Bruce Westerman (R-AR), Ron Wyden (D-OR), and Sheldon Whitehouse (D-RI) have bought shares of Eli Lilly and Company in the last year totaling $212,000. Lisa C. McClain (R-MI), Jonathan L. Jackson (D-IL), Gilbert Ray Cisneros, Jr. (D-CA), Ro Khanna (D-CA), Josh Gottheimer (D-NJ), Jefferson Shreve (R-IN), Bruce Westerman (R-AR), Tommy Tuberville (R-AL), Dan Newhouse (R-WA), Robert Bresnahan, Jr. (R-PA), Julie Johnson (D-TX), Ron Wyden (D-OR), and Greg Landsman (D-OH) have sold shares totaling $531,500. Eli Lilly and Company Key ExecutivesMr. David A. Ricks (Age 56)Chairman, CEO & President Compensation: $6.29M1 recent tradesDr. Daniel M. Skovronsky M.D. (Age 50)Ph.D., EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology Compensation: $3.82MMs. Anat Hakim J.D. (Age 55)Executive VP, General Counsel & Secretary Compensation: $2.81MMr. Jacob S. Van Naarden (Age 39)Executive VP & President of Loxo Compensation: $2.38MMr. Gordon BrooksGroup VP, Controller & Corporate Strategy and Interim CFOMr. Donald A. ZakrowskiSenior VP of Finance & Chief Accounting Officer1 recent tradesMr. Diogo Rau (Age 49)EVP & Chief Information and Digital Officer Compensation: $1.06MMr. Alonzo Weems (Age 53)EVP of Enterprise Risk Management and Chief Ethics & Compliance Officer Mr. Eric Dozier (Age 56)Executive Vice President of Human Resources & Diversity Mr. Jeffrey N. Simmons (Age 57)Senior VP & President of Elanco Animal Health Compensation: $1.73M More Insider Trading Tools from MarketBeat Related Companies AMGN Insider Ownership BIIB Insider Ownership INCY Insider Ownership MRNA Insider Ownership VKTX Insider Ownership VRTX Insider Ownership ABBV Insider Ownership JNJ Insider Ownership MRK Insider Ownership PFE Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NYSE:LLY) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access